Fig. 6From: Comprehensive stability-indicating method development of Avanafil Phosphodiesterase type 5 inhibitor using advanced Quality-by-Design approachOverlay chromatogram of AV (100 μg/mL) in (a) acid hydrolysis, alkaline hydrolysis and peroxide and (b) photolytic and thermal degradation in the optimized chromatographic conditionBack to article page